{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:00:52Z","timestamp":1792101652017,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.exer.2021.108460","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T01:44:28Z","timestamp":1611366268000},"page":"108460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-123X","authenticated-orcid":false,"given":"W.H.G.","family":"Hubens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9406-1426","authenticated-orcid":false,"given":"H.J.M.","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.G.M.F.","family":"Gorgels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.B.","family":"Webers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.exer.2021.108460_bib1","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/acs.jproteome.8b00244","article-title":"Proteomic analysis of aqueous humor from primary open angle glaucoma patients on drug treatment revealed altered complement activation cascade","volume":"17","author":"Adav","year":"2018","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.exer.2021.108460_bib2","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41433-019-0501-4","article-title":"Early local activation of complement in aqueous humour of patients with age-related macular degeneration","volume":"33","author":"Altay","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108460_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00347-014-3100-6","article-title":"Complement activation after induction of ocular hypertension in an animal model","volume":"112","author":"Becker","year":"2015","journal-title":"Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft"},{"key":"10.1016\/j.exer.2021.108460_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2174\/1570159X15666170720094529","article-title":"Modulation of the immune system for the treatment of glaucoma","volume":"16","author":"Bell","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.exer.2021.108460_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1101","article-title":"Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire","volume":"9","author":"Beutgen","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.exer.2021.108460_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1076\/ceyr.27.4.253.16603","article-title":"In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system","volume":"27","author":"Blondin","year":"2003","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108460_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","article-title":"Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma","volume":"26","author":"Bosco","year":"2018","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.exer.2021.108460_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.141.2.553","article-title":"The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential","volume":"141","author":"Burger","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib9","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41467-018-05681-9","article-title":"Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2021.108460_bib10","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.4049\/jimmunol.162.6.3212","article-title":"Human 60-kDa heat-shock protein: a danger signal to the innate immune system","volume":"162","author":"Chen","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-017-0649-6","article-title":"The eye as a complement dysregulation hotspot","volume":"40","author":"Clark","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.exer.2021.108460_bib12","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.18632\/oncotarget.22963","article-title":"A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma","volume":"9","author":"Gallenkamp","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.exer.2021.108460_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00055735-199704000-00007","article-title":"New definitions of glaucoma","volume":"8","author":"Gupta","year":"1997","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108460_bib14","doi-asserted-by":"crossref","first-page":"E3839","DOI":"10.1073\/pnas.1608769114","article-title":"Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective","volume":"114","author":"Harder","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.exer.2021.108460_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12974-020-02011-z","article-title":"Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA\/2J mice","volume":"17","author":"Harder","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108460_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-10-76","article-title":"Deficiency of complement component 5 ameliorates glaucoma in DBA\/2J mice","volume":"10","author":"Howell","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108460_bib17","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1016\/j.exer.2020.108077","article-title":"The aqueous humor proteome of primary open angle glaucoma: an extensive review","volume":"197","author":"Hubens","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108460_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preteyeres.2013.09.001","article-title":"The vast complexity of primary open angle glaucoma: disease genes, risks, molecular mechanisms and pathobiology","volume":"37","author":"Janssen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108460_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/sji.12167","article-title":"Complement activation and its prognostic role in post-cardiac arrest patients","volume":"79","author":"Jenei","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib20","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.molimm.2011.07.012","article-title":"Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma","volume":"48","author":"Jha","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis","volume":"100","author":"Kapetanakis","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108460_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fimmu.2015.00215","article-title":"Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH","volume":"6","author":"Kenawy","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.exer.2006.03.002","article-title":"Retinal synthesis and deposition of complement components induced by ocular hypertension","volume":"83","author":"Kuehn","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108460_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12026-012-8327-1","article-title":"Complement regulation of T cell immunity","volume":"54","author":"Kwan","year":"2012","journal-title":"Immunol. Res."},{"key":"10.1016\/j.exer.2021.108460_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: the Barbados eye studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108460_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/IJG.0000000000001014","article-title":"Decreased serum levels of complement C3 reflect complement system dysregulation in patients with primary open-angle glaucoma: results from a pilot study","volume":"27","author":"Li","year":"2018","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2021.108460_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.61.11.39","article-title":"Complement activation in the vitreous of patients with proliferative diabetic retinopathy","volume":"61","author":"Mandava","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108460_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.1997.13.23","article-title":"Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor","volume":"13","author":"Maren","year":"1997","journal-title":"J. Ocul. Pharmacol. Therapeut. : the official journal of the Association for Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.exer.2021.108460_bib31","doi-asserted-by":"crossref","first-page":"12685","DOI":"10.1038\/s41598-017-12858-7","article-title":"Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes","volume":"7","author":"Mirzaei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2021.108460_bib32","article-title":"Increased infiltration of immune cell subsets and altered soluble factor profile in aqueous humor of glaucoma patients correlates with disease severity","volume":"60","author":"Nair","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108460_bib33","first-page":"1","article-title":"Evidence for activation of lectin and classical pathway complement components in aqueous humor of neovascular age-related macular degeneration","author":"Omori","year":"2019","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2021.108460_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000503258","article-title":"Evidence for activation of lectin and classical pathway complement components in aqueous humor of neovascular age-related macular degeneration","volume":"63","author":"Omori","year":"2020","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2021.108460_bib36","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2021.108460_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3389\/fphar.2019.01381","article-title":"Intravitreal therapy against the complement factor C5 prevents retinal degeneration in an experimental autoimmune glaucoma model","volume":"10","author":"Reinehr","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2021.108460_bib38","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1038\/s41598-018-28183-6","article-title":"S100B immunization triggers NFkappaB and complement activation in an autoimmune glaucoma model","volume":"8","author":"Reinehr","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2021.108460_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fncel.2016.00140","article-title":"Simultaneous complement response via lectin pathway in retina and optic nerve in an experimental autoimmune glaucoma model","volume":"10","author":"Reinehr","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exer.2021.108460_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2017.05.013","article-title":"Complement in clinical medicine: clinical trials, case reports and therapy monitoring","volume":"89","author":"Ricklin","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.exer.2021.108460_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jnr.1197","article-title":"Expression of small heat shock proteins and intermediate filaments in the human optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro","volume":"66","author":"Salvador-Silva","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2021.108460_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/eye.2016.328","article-title":"Local complement activation in aqueous humor in patients with age-related macular degeneration","volume":"31","author":"Schick","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108460_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1189\/jlb.0306167","article-title":"Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy","volume":"81","author":"Schmitt","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.exer.2021.108460_bib44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.exer.2021.108460_bib45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1167\/iovs.05-0830","article-title":"Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes","volume":"47","author":"Stasi","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108460_bib46","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1167\/iovs.10-5289","article-title":"Oxidative stress and the regulation of complement activation in human glaucoma","volume":"51","author":"Tezel","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108460_bib47","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108460_bib48","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fnins.2019.00931","article-title":"Immune mediated degeneration and possible protection in glaucoma","volume":"13","author":"Tsai","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2021.108460_bib49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00417-005-1195-9","article-title":"IOP and the risk of progression to glaucoma","volume":"243","author":"Weinreb","year":"2005","journal-title":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"10.1016\/j.exer.2021.108460_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-016-0091-6","article-title":"Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma","volume":"11","author":"Williams","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.exer.2021.108460_bib51","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1167\/iovs.18-26129","article-title":"T-lymphocyte subset distribution and activity in patients with glaucoma","volume":"60","author":"Yang","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108460_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-1759(89)90169-5","article-title":"Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope","volume":"121","author":"Zilow","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.exer.2021.108460_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.1990.tb05171.x","article-title":"Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome","volume":"79","author":"Zilow","year":"1990","journal-title":"Clin. Exp. Immunol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:29:37Z","timestamp":1762147777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":51,"alternative-id":["S0014483521000257"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108460","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108460"}}